Short answer
LIFECORE BIOMEDICAL, INC. DE (LFCR) filed an 8-K current report with the SEC on March 5, 2026 reporting Item 5.08 (Shareholder Director Nominations). Fiscal year changed from last-Sunday-of-May end to calendar year (Dec 31), effective for transition period May 26–Dec 31, 2025.
LIFECORE BIOMEDICAL, INC. DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.08 · Shareholder Director Nominations
- Fiscal year changed from last-Sunday-of-May end to calendar year (Dec 31), effective for transition period May 26–Dec 31, 2025
- 2026 Annual Meeting set for June 4, 2026: shifted >30 days from prior year's Oct 29, 2025 meeting date
- Shareholder proposal/nomination deadline: March 16, 2026, under Rules 14a-8, 14a-18, and 14a-19(b)
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LIFECORE BIOMEDICAL, INC. DE 8-K filings
Get the next LFCR 8-K as it lands
Follow LFCR for push alerts, or ask the research agent what this filing means.